Abstract
PURPOSEMultigene panel testing (MGPT) identifies TP53 pathogenic or likely pathogenic (P/LP) variants in patients with diverse phenotypes, of which only one is class...
Cite
CITATION STYLE
APA
Schwartz, A. N., Cahill, S. R., Stokes, S. M., Castillo, D., Tung, N. M., Weitzel, J. N., … Garber, J. E. (2021). Evaluation of TP53 Variants Detected on Peripheral Blood or Saliva Testing: Discerning Germline From Somatic TP53 Variants. JCO Precision Oncology, (5), 1677–1686. https://doi.org/10.1200/po.21.00278
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free